SORCS1 Alters Amyloid Precursor Protein Processing and Variants May Increase Alzheimer's Disease Risk

Objective: Sorting mechanisms that cause the amyloid precursor protein (APP) and the beta-secretases and gamma-secretases to colocalize in the same compartment play an important role in the regulation of A beta production in Alzheimer's disease (AD). We and others have reported that genetic variants in the Sortilin-related receptor (SORL1) increased the risk of AD, that SORL1 is involved in trafficking of APP, and that underexpression of SORL1 leads to overproduction of A beta. Here we explored the role of one of its homologs, the sortilin-related VPS10 domain containing receptor 1 (SORCS1), in AD. Methods: We analyzed the genetic associations between AD and 16 SORCS1 single nucleotide polymorphisms (SNPs) in 6 independent data sets (2,809 cases and 3,482 controls). In addition, we compared SorCS1 expression levels of affected and unaffected brain regions in AD and control brains in microarray gene expression and real-time polymerase chain reaction (RT-PCR) sets, explored the effects of significant SORCS1-SNPs on SorCS1 brain expression levels, and explored the effect of suppression and overexpression of the common SorCS1 isoforms on APP processing and A beta generation. Results: Inherited variants in SORCS1 were associated with AD in all datasets (0.001 < p < 0.049). In addition, SorCS1 influenced APP processing. While overexpression of SorCS1 reduced gamma-secretase activity and A beta levels, the suppression of SorCS1 increased gamma-secretase processing of APP and the levels of A beta. Interpretations: These data suggest that inherited or acquired changes in SORCS1 expression or function may play a role in the pathogenesis of AD. ANN NEUROL 2011;69:47-64